| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.34 | 5e-15 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.28 | 3e-14 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.19 | 1e-07 |
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-06 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-05 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.18 | 4e-05 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.81 | 0.002 |